The Guillain-Barré syndrome. A clinical and electrodiagnostic study of 25 cases.
D000200:Action Potentials; D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis; D002648:Child; D004558:Electric Stimulation; D004576:Electromyography; D005071:Evoked Potentials; D005154:Facial Nerve / Q000503:physiopathology; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008475:Median Nerve / Q000503:physiopathology; D008875:Middle Aged; D009121:Muscle Denervation; D009132:Muscles / Q000503:physiopathology; D009431:Neural Conduction; D009801:Oculomotor Muscles / Q000503:physiopathology; D010525:Peripheral Nerves / Q000503:physiopathology*; D010543:Peroneal Nerve / Q000503:physiopathology; D011128:Polyradiculopathy / Q000134:cerebrospinal fluid / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D011379:Prognosis; D013997:Time Factors; D014459:Ulnar Nerve / Q000503:physiopathology
D002556:Cerebrospinal Fluid Proteins; D005938:Glucocorticoids; D000324:Adrenocorticotropic Hormone